Open AccessPM426. Effect of a glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, on cognition and body weight during antipsychotic treatment
Author(s) -
Ivana Babič Božović,
Ashleigh Gorak,
Jessica R Hughes,
Martin Engel,
Donna Sellers,
Paul L. Else,
L Lufe,
A. Obeid,
A.L. Osborne,
Le Mesurier P,
Nagesh Pai,
XuFeng Huang,
Katrina Weston–Green
Publication year - 2016
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyw041.426
Subject(s) - liraglutide , glucagon like peptide 1 receptor , glucagon like peptide 1 , agonist , medicine , pharmacology , endocrinology , cognition , receptor , diabetes mellitus , type 2 diabetes , psychiatry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom